Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein

Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein

US Patent 6489299 · Granted Dec 3, 2002

Estimated economic value: $19,189,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Indirect homogeneous mobility shift assays for the detection of biologics in pat2023
Biomarkers for assessing subjects with multiple sclerosis2023
Replacement gene tolerizing vectors and methods of use thereof2020
Antibodies to microbiome, stress factors and mast cell markers as diagnostic mar2019
Aquaporin tolerizing vaccines and methods of use thereof2018
Small heat shock proteins and active fragments thereof as a therapy for inflamma2018
HER2DELTA16 peptides2018
HER2Delta16 peptides2017
Amyloid beta peptides as therapy for multiple sclerosis2017
Fibrinogen immune complexes to diagnose and guide therapy in rheumatoid arthriti2015
HER2Delta16 peptides2015
Alpha B-crystallin as a therapy for multiple sclerosis2014